Diagnostic yield in copy number variant analysis studies of short stature patients
References . | n . | Selection criteria . | Diagnostic yield . | Short stature genes/microdeletion/duplication region . |
---|---|---|---|---|
Zahnleiter et al (54) | 200 | Idiopathic short stature—sporadic in 92 and familial in 108 | 10% | PAX3, POMC, GCKR, 22q11, 3q29, 1q21, 2q33, 1p36, and 1q21 |
Canton et al (55) | 51 | Born SGA with short stature present at ≥ 4 years. One of intellectual disability, developmental delay, or dysmorphic features | 16% | 22q11, 10q26, GAB1, IGFBP2, CSNK2A1, CHD8, GALNS, MIR421 |
Wit et al (56) | 49 | Born SGA with short stature present at ≥ 3 years | 16% | mUPD7, mUPD14, SHOX, 15q26, 22q11, 2q31, 7p21, 8q24 |
Van Duyvenvoorde et al (57) | 162 | Short stature of unknown origin both normal size and small at birth included | 12% | SHOX, IGF1R, 15q26, 7q3, 1q44 |
Hu et al (58) | 119 | Idiopathic short stature. SGA children excluded. | 4% | 22q11, 4q11, 4q12, Yp11 |
Homma et al (59) | 229 | Short stature with dysmorphic features and developmental delay | 14% | 1p36, 2p15, 2q31.1, Wolf–Hirschhorn syndrome, 12q14, Temple syndrome, 15q11, Smith–Magenis syndrome, NF1 deletion syndrome, Miller–Dieker syndrome, 22q11 deletion, SHOX |
Hars-Isono et al (17) | 86 | Short stature aged ≥ 2 years. Born SGA | 9% | 1q21, 22q11, Xp22.33, 19p13.12, 5q35, 10q36 |
References . | n . | Selection criteria . | Diagnostic yield . | Short stature genes/microdeletion/duplication region . |
---|---|---|---|---|
Zahnleiter et al (54) | 200 | Idiopathic short stature—sporadic in 92 and familial in 108 | 10% | PAX3, POMC, GCKR, 22q11, 3q29, 1q21, 2q33, 1p36, and 1q21 |
Canton et al (55) | 51 | Born SGA with short stature present at ≥ 4 years. One of intellectual disability, developmental delay, or dysmorphic features | 16% | 22q11, 10q26, GAB1, IGFBP2, CSNK2A1, CHD8, GALNS, MIR421 |
Wit et al (56) | 49 | Born SGA with short stature present at ≥ 3 years | 16% | mUPD7, mUPD14, SHOX, 15q26, 22q11, 2q31, 7p21, 8q24 |
Van Duyvenvoorde et al (57) | 162 | Short stature of unknown origin both normal size and small at birth included | 12% | SHOX, IGF1R, 15q26, 7q3, 1q44 |
Hu et al (58) | 119 | Idiopathic short stature. SGA children excluded. | 4% | 22q11, 4q11, 4q12, Yp11 |
Homma et al (59) | 229 | Short stature with dysmorphic features and developmental delay | 14% | 1p36, 2p15, 2q31.1, Wolf–Hirschhorn syndrome, 12q14, Temple syndrome, 15q11, Smith–Magenis syndrome, NF1 deletion syndrome, Miller–Dieker syndrome, 22q11 deletion, SHOX |
Hars-Isono et al (17) | 86 | Short stature aged ≥ 2 years. Born SGA | 9% | 1q21, 22q11, Xp22.33, 19p13.12, 5q35, 10q36 |
Diagnostic yield in copy number variant analysis studies of short stature patients
References . | n . | Selection criteria . | Diagnostic yield . | Short stature genes/microdeletion/duplication region . |
---|---|---|---|---|
Zahnleiter et al (54) | 200 | Idiopathic short stature—sporadic in 92 and familial in 108 | 10% | PAX3, POMC, GCKR, 22q11, 3q29, 1q21, 2q33, 1p36, and 1q21 |
Canton et al (55) | 51 | Born SGA with short stature present at ≥ 4 years. One of intellectual disability, developmental delay, or dysmorphic features | 16% | 22q11, 10q26, GAB1, IGFBP2, CSNK2A1, CHD8, GALNS, MIR421 |
Wit et al (56) | 49 | Born SGA with short stature present at ≥ 3 years | 16% | mUPD7, mUPD14, SHOX, 15q26, 22q11, 2q31, 7p21, 8q24 |
Van Duyvenvoorde et al (57) | 162 | Short stature of unknown origin both normal size and small at birth included | 12% | SHOX, IGF1R, 15q26, 7q3, 1q44 |
Hu et al (58) | 119 | Idiopathic short stature. SGA children excluded. | 4% | 22q11, 4q11, 4q12, Yp11 |
Homma et al (59) | 229 | Short stature with dysmorphic features and developmental delay | 14% | 1p36, 2p15, 2q31.1, Wolf–Hirschhorn syndrome, 12q14, Temple syndrome, 15q11, Smith–Magenis syndrome, NF1 deletion syndrome, Miller–Dieker syndrome, 22q11 deletion, SHOX |
Hars-Isono et al (17) | 86 | Short stature aged ≥ 2 years. Born SGA | 9% | 1q21, 22q11, Xp22.33, 19p13.12, 5q35, 10q36 |
References . | n . | Selection criteria . | Diagnostic yield . | Short stature genes/microdeletion/duplication region . |
---|---|---|---|---|
Zahnleiter et al (54) | 200 | Idiopathic short stature—sporadic in 92 and familial in 108 | 10% | PAX3, POMC, GCKR, 22q11, 3q29, 1q21, 2q33, 1p36, and 1q21 |
Canton et al (55) | 51 | Born SGA with short stature present at ≥ 4 years. One of intellectual disability, developmental delay, or dysmorphic features | 16% | 22q11, 10q26, GAB1, IGFBP2, CSNK2A1, CHD8, GALNS, MIR421 |
Wit et al (56) | 49 | Born SGA with short stature present at ≥ 3 years | 16% | mUPD7, mUPD14, SHOX, 15q26, 22q11, 2q31, 7p21, 8q24 |
Van Duyvenvoorde et al (57) | 162 | Short stature of unknown origin both normal size and small at birth included | 12% | SHOX, IGF1R, 15q26, 7q3, 1q44 |
Hu et al (58) | 119 | Idiopathic short stature. SGA children excluded. | 4% | 22q11, 4q11, 4q12, Yp11 |
Homma et al (59) | 229 | Short stature with dysmorphic features and developmental delay | 14% | 1p36, 2p15, 2q31.1, Wolf–Hirschhorn syndrome, 12q14, Temple syndrome, 15q11, Smith–Magenis syndrome, NF1 deletion syndrome, Miller–Dieker syndrome, 22q11 deletion, SHOX |
Hars-Isono et al (17) | 86 | Short stature aged ≥ 2 years. Born SGA | 9% | 1q21, 22q11, Xp22.33, 19p13.12, 5q35, 10q36 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.